HPV-Associated Oropharyngeal Cancers Increasing in the U.S.
Thursday, October 20, 2016
A new national report on cancer incidence trends 1 presents data of relevance for dentists and the public. First, the report provides encouraging long-term data on declining death rates for several common cancer types, but it also presents significant data on the increasing incidence rates of human papillomavirus (HPV)-associated cancers of the oropharynx, including the base of the tongue and tonsils.
Accelerating the HPV Vaccine Uptake: Urgency for Action to Prevent Cancer
Friday, September 9, 2016
Human papillomaviruses (HPV) cause most cases of cervical cancer and large proportions of vaginal, vulvar, anal, penile, and oropharyngeal cancers. HPV also causes genital warts and recurrent respiratory papillomatosis. HPV vaccines could dramatically reduce the incidence of HPV-associated cancers and other conditions among both females and males, but uptake of the vaccines has fallen short of target levels. The President's Cancer Panel finds underuse of HPV vaccines a serious but correctable threat to progress against cancer. In this report, the Panel presents four goals to increase HPV vaccine uptake: three of these focus on the United States and the fourth addresses ways the United States can help to increase global uptake of the vaccines. Several high-priority research questions related to HPV and HPV vaccines also are identified...
Human papillomavirus: a strong case for vaccinating boys
Friday, September 9, 2016
In the UK, human papilloma virus vaccination is restricted on the NHS to girls and only recently been recommended for men who have sex with men. The restriction is based largely on cost-effectiveness. In this article, Gillian Prue sets out the compelling case for vaccinating all boys. On page 10, Peter Baker describes HPV Action’s campaign for gender-neutral HPV vaccination.
What are the key statistics about oral cavity and oropharyngeal cancers?
Wednesday, August 31, 2016
The American Cancer Society’s most recent estimates for oral cavity and oropharyngeal cancers in the United States are for 2016:
- About 48,330 people will get oral cavity or oropharyngeal cancer.
- An estimated 9,570 people will die of these cancers.
These cancers are more than twice as common in men as in women...
HPV risk for oral cancer | Dana-Farber Cancer Institute
Saturday, July 30, 2016
Could Making Cancer Screening Simpler Increase Women's Risk?
Friday, October 13, 2017
A proposal to simplify cervical cancer screening could end up missing some cancers, researchers and patient advocates say. And that could be especially true for minority women.
Sweetening connection between cancer and sugar
Tuesday, May 30, 2017
Scientists have found that some types of cancers have more of a sweet tooth than others.
What you should know about Cervical Cancer
Thursday, February 16, 2017
Unlike many gynecologic cancers, there is a vaccination and screening test for cervical cancer, an important distinction in preventing and identifying the disease, according to Ursula Matulonis, MD, medical director of Gynecologic Oncology in Dana-Farber’s Susan F. Smith Center for Women’s Cancers, and Colleen Feltmate, MD, director of minimally invasive surgery in Gynecologic Oncology at Brigham and Women’s Hospital.
Wider Racial Gap Found in Cervical Cancer Deaths
Monday, January 23, 2017
Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond
Tuesday, June 30, 2015
Despite the declining incidence of cervical cancer as a result of the introduction of screening programs, globally it remains a leading cause of cancer-related death in women. Outcomes for patients who are diagnosed with anything but early-stage disease remain poor.